Most manufacturers know Inmar for pharmacy returns and consumer drug takeback programs. But according to Inmar's Head of Industry Health, Emily Welker, the company's unique combination of healthcare and retail data is creating new opportunities in health media. In this video interview, Welker discusses how Inmar applies insights from both sides of its business to better understand consumer behavior, including the evolving impact of GLP-1 therapies. Rather than viewing GLP-1 users as a single audience, she explains why marketers should consider treatment stage, purpose of use and changing purchasing habits to deliver more relevant engagement. Welker also shares a measured example of how privacy-compliant audience targeting helped a dairy brand reach consumers seeking high-protein options, resulting in a 7.5x return on ad spend. Their conversation explores how healthcare, retail and media data can work together to create more meaningful consumer connections.